Tag Archives: biologics

Mar1

Apples and Oranges?

Biosimilars: The Sophistication of Generics Biologics—therapeutics derived from living cells—remain complex to produce…and reproduce.  Due to the molecular and structural complexity of large (relatively speaking) biologic proteins, a generic biologic equivalent can only be made “similar,” not identical, to the original, hence the industry term “biosimilar”—this is unlike small-molecule drugs, whose chemical structures can be […]

Posted in Efficacy, Technology | Also tagged , , | Comments closed